Twitter
Link your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PYPD - PolyPid: Strong Pipeline Close Catalysts
April, 19 2022 12:19 PM
PolyPid Ltd.
PolyPid develops a platform technology to provide locally controlled and continuous delivery of medications. Lead product candidate D-PLEX100 is investigated for the prevention of sternal and abdominal surgical site infections serving a huge market. Meaningful interim results and topline data from pivotal Phase 3 SHIELD I clinical trial will soon be published. Measured in terms of the clinical benefit of D?PLEX100 and its estimated market size, PolyPid is clearly undervalued at present in our view. For further details see:
PolyPid: Strong Pipeline, Close Catalysts
Stock Information
Company Name:
PolyPid Ltd.
Stock Symbol:
PYPD
Market:
NASDAQ
Website:
polypid.com
Get PYPD Alerts
News, Short Squeeze, Breakout and More Instantly...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer .